Vimarsana
Biggest News Aggregation in the World

Auriga Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Auriga Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Auriga Partners Today - Breaking & Trending Today

Exeliom Biosciences Raises Additional €8M; Closes €24M Series A Round - Vimarsana News

Exeliom Biosciences Raises Additional €8M; Closes €24M Series A Round

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Pherecydes Pharma: PHERECYDES Strengthens its Corporate Links with ERYTECH to Prepare the Strategic Combination - Vimarsana News

Pherecydes Pharma: PHERECYDES Strengthens its Corporate Links with ERYTECH to Prepare the Strategic Combination

Entry into a definitive merger agreement between PHERECYDES and ERYTECH Combination with ERYTECH to be submitted to shareholders' vote on June 23, 2023 Completion of a contribution in

Akkadian Partners SA: Akkadian Partners Fund has Acquired Over a 5% Shareholding and Voting Rights in Erytech and Intends to Vote Against the Merger between Erytech and Pherecydes - Vimarsana News

Akkadian Partners SA: Akkadian Partners Fund has Acquired Over a 5% Shareholding and Voting Rights in Erytech and Intends to Vote Against the Merger between Erytech and Pherecydes

PARIS, FRANCE/ ACCESSWIRE / May 16, 2023 / Akkadian Partners SA ("Akkadian") has announced that Akkadian Partners Fund, a Luxemburg registered securitisation fund under its management, now holds over a

AKKADIAN PARTNERS: Akkadian Partners Fund has acquired over a 5% shareholding and voting rights in Erytech - Vimarsana News

AKKADIAN PARTNERS: Akkadian Partners Fund has acquired over a 5% shareholding and voting rights in Erytech

Paris - 12 May 2023 - 6pm - Akkadian Partners SA ("Akkadian") has announced that Akkadian Partners Fund, a Luxemburg registered securitisation fund under its management, now holds over a 5% shareholding

Pherecydes Pharma: ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies - Vimarsana News

Pherecydes Pharma: ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies

Conference call and webcast in English on February 16, 2023 at 8:30am EST 02:30pm CET and in French on the same day at 12pm EST 6pm CET Strategic combination would build on complementary expertise